RESUMEN
Experimental colitis in mice is characterized by infiltration of activated T helper (Th) cells and macrophages into the lamina propria. Particularly, these cells expressed CD44 variant exon 7 (CD44v7)-containing isoforms. Upregulation of CD44v7 isoforms was induced by CD40 ligation, an inflammation-driving interaction between activated Th cells and macrophages. To define the role of CD44v7 in colitis, mice bearing a targeted deletion for exon v7 were generated. In trinitrobenzene sulfonic acid-induced colitis, wild-type mice developed severe signs of persistent inflammation. Mice lacking CD44v7 initially showed unspecific inflammation, then recovered completely. The pathogenic origin was shown to reside in bone marrow-derived CD44v7(+) cells, because adoptive transfer experiments demonstrated an absolute requirement for CD44v7 on hematopoietic cells for maintenance of colitis. Interleukin (IL)-10-deficient mice, which develop a chronic Th1-driven enterocolitis, were crossbred with CD44v6/v7 null mice. In IL-10 x CD44v6/v7 double deficient mice, intestinal inflammation developed only weakly and at an older age. Analysis of cell death in the inflamed lesions revealed that mononuclear cells in the CD44v7 null infiltrates had higher rates of apoptosis than those from wild-type mice. Thus, the region encoded by CD44v7 appears to be essential for survival of effector lymphocytes, resulting in persistence of inflammation.
Asunto(s)
Apoptosis , Colitis/inmunología , Receptores de Hialuranos/genética , Enfermedades Inflamatorias del Intestino/inmunología , Traslado Adoptivo , Animales , Trasplante de Médula Ósea , Antígenos CD40 , Colitis/etiología , Colon/patología , Exones , Enfermedades Inflamatorias del Intestino/etiología , Interleucina-10/genética , Mucosa Intestinal/patología , Ratones , Ratones Noqueados , Isoformas de Proteínas/genética , Quimera por Radiación , Ácido Trinitrobencenosulfónico/farmacologíaRESUMEN
CD44, the major cell surface receptor for hyaluronic acid (HA), was shown to localize to detergent-resistant cholesterol-rich microdomains, called lipid rafts, in fibroblasts and blood cells. Here, we have investigated the molecular environment of CD44 within the plane of the basolateral membrane of polarized mammary epithelial cells. We show that CD44 partitions into lipid rafts that contain annexin II at their cytoplasmic face. Both CD44 and annexin II were released from these lipid rafts by sequestration of plasma membrane cholesterol. Partition of annexin II and CD44 to the same type of lipid rafts was demonstrated by cross-linking experiments in living cells. First, when CD44 was clustered at the cell surface by anti-CD44 antibodies, annexin II was recruited into the cytoplasmic leaflet of CD44 clusters. Second, the formation of intracellular, submembranous annexin II-p11 aggregates caused by expression of a trans-dominant mutant of annexin II resulted in coclustering of CD44. Moreover, a frequent redirection of actin bundles to these clusters was observed. These basolateral CD44/annexin II-lipid raft complexes were stabilized by addition of GTPgammaS or phalloidin in a semipermeabilized and cholesterol-depleted cell system. The low lateral mobility of CD44 in the plasma membrane, as assessed with fluorescent recovery after photobleaching (FRAP), was dependent on the presence of plasma membrane cholesterol and an intact actin cytoskeleton. Disruption of the actin cytoskeleton dramatically increased the fraction of CD44 which could be recovered from the light detergent-insoluble membrane fraction. Taken together, our data indicate that in mammary epithelial cells the vast majority of CD44 interacts with annexin II in lipid rafts in a cholesterol-dependent manner. These CD44-containing lipid microdomains interact with the underlying actin cytoskeleton.
Asunto(s)
Actinas/metabolismo , Anexina A2/metabolismo , Citoesqueleto/metabolismo , Células Epiteliales/metabolismo , Receptores de Hialuranos/metabolismo , Lípidos de la Membrana/metabolismo , beta-Ciclodextrinas , Animales , Anexina A2/genética , Anexina A2/inmunología , Línea Celular , Membrana Celular/efectos de los fármacos , Membrana Celular/metabolismo , Polaridad Celular , Colesterol/metabolismo , Ciclodextrinas/farmacología , Citoesqueleto/efectos de los fármacos , Células Epiteliales/citología , Células Epiteliales/efectos de los fármacos , Guanosina 5'-O-(3-Tiotrifosfato)/metabolismo , Receptores de Hialuranos/inmunología , Glándulas Mamarias Animales/citología , Ratones , Mutación , Faloidina/farmacología , Polímeros , Agregación de Receptores/efectos de los fármacos , Proteínas Recombinantes de Fusión/metabolismo , SolubilidadRESUMEN
CD44 is a transmembrane molecule appearing in numerous isoforms generated by insertions of alternatively spliced variant exons (CD44v) and having various binding partners. CD44v7 on T cells was proposed to promote colitis by preventing T-cell apoptosis. Here we demonstrate that Cd44v7-deficient T cells - like Cd44 wild-type (Cd44WT) T cells - provoked disease in two different colitis models: the model induced by CD4+CD45RBhigh T-cell transfer into Rag2-deficient mice and a new model based on ovalbumin (OVA)-specific T-cell transfer into Rag-sufficient, OVA-challenged mice. In contrast, CD44v7 absence on macrophages in recipient mice prevented colitis. Prevention was associated with the downregulation of signal transducer and activator of transcription 3 (STAT3)-activating and Foxp3-counteracting interleukin-6 (IL-6), lower numbers of phospho-STAT3-containing lymphocytes, and higher Foxp3+ T-cell counts in the colon. Consequently, the protected colons showed lower IL-12, IL-1ß expression, and decreased interferon-γ levels. Importantly, stimulation of T cells by Cd44v7-deficient macrophages induced upregulation of Foxp3 in vitro, while cotransfer of Cd44WT macrophages into Cd44v7-deficient mice reduced Foxp3+ T-cell counts and caused colitis. Accordingly, the CD44v7 ligand osteopontin, whose levels were elevated in Crohn's disease, specifically induced IL-6 in human monocytes, a cytokine also increased in these patients. We suggest macrophage-specific targeting of the CD44v7 pathway as a novel therapeutic option for Crohn's disease.
Asunto(s)
Colitis/inmunología , Enfermedad de Crohn/inmunología , Receptores de Hialuranos/metabolismo , Macrófagos/fisiología , Subgrupos de Linfocitos T/fisiología , Linfocitos T Reguladores/fisiología , Adulto , Empalme Alternativo , Animales , Células Cultivadas , Técnicas de Cocultivo , Citocinas/metabolismo , Modelos Animales de Enfermedad , Exones/genética , Femenino , Factores de Transcripción Forkhead/metabolismo , Humanos , Receptores de Hialuranos/genética , Mediadores de Inflamación/metabolismo , Masculino , Ratones , Ratones Endogámicos BALB C , Ratones Noqueados , Ratones Transgénicos , Osteopontina/metabolismoRESUMEN
Resident epidermal Langerhans cells (LC) in adult mice express ADPase, major histocompatibility complex (MHC) class II, and CD205 and CD207 molecules, while the first dendritic leukocytes that colonize the fetal and newborn epidermis are only ADPase(+). In this study, we tested whether dendritic epidermal leukocytes (DEL) are end-stage cells or represent LC precursors. In epidermal sheets of fetal and neonatal mice, we found no apoptotic leukocytes, suggesting that these cells do not die in situ. To address whether DEL can give rise to LC, sorted DEL from murine newborn skin were cultured with cytokines used to generate LC from human CD34(+) precursors. After 7-14 days, DEL proliferated and acquired the morphology and phenotype of cells reminiscent of LC. In concordance with this finding, we show that neonatal epidermis harbors 10-20 times the number of cycling MHC class II(+) leukocytes as adult tissue. To test whether LC can differentiate from skin precursors in vivo, we developed a transplantation model. As it was impossible to transplant fetal epidermis, whole fetal skin was grafted onto adult severe combined immunodeficient mice. As opposed to the uniform absence of donor LC at the time of transplantation, examination of the epidermis from the grafts after 2-4 weeks revealed MHC class II(+) donor cells, which had acquired CD205 and CD207, thus qualifying them as LC. Finally, we present evidence that endogenous LC persist in skin grafts for the observation period of 45 days. These studies show that hematopoietic precursors seed the skin during embryonic life and can give rise to LC.
Asunto(s)
Células de Langerhans/citología , Piel/citología , Células Madre/citología , Animales , Animales Recién Nacidos , Apoptosis/fisiología , Ciclo Celular/fisiología , Femenino , Antígenos de Histocompatibilidad Clase II/fisiología , Humanos , Células de Langerhans/fisiología , Leucocitos/citología , Leucocitos/fisiología , Masculino , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos C57BL , Ratones SCID , Fenotipo , Embarazo , Piel/embriología , Piel/crecimiento & desarrollo , Células Madre/fisiologíaRESUMEN
There is ample evidence that the family of CD44 glycoproteins is involved in homing, maturation and activation of lymphocytes. Furthermore, recent evidence suggests that CD44 splice variants are particularly involved in the process of lymphocyte activation whereby it was hypothesized that different isoforms may fulfill distinct functions. We here addressed the question of CD44v6 and CD44v7 being involved in TH1 and TH2 reactions using as model systems for TH1 activation a TNBS-induced colitis and a DNFB-induced DTH reaction and for TH2 activation a FITC-induced allergic dermatitis. With the exception of a small subpopulation of lymphocytes in Peyer's patches, expression of neither CD44v6 nor CD44v7 was noted in the absence of an antigenic stimulus. Both CD44 variant exons are transiently detected on T lymphocytes during mounting of an immune response. In vitro studies revealed that antibodies against both CD44v6 and CD44v7 inhibited lymphocyte proliferation and cytokine production. Based on these findings the efficiency of anti-CD44v6 and anti-CD44v7 treatment was evaluated in vivo in TH1 and TH2 dependent autoimmune and DTH reactions. Anti-CD44v7 completely abrogated development of a death promoting colitis and anti-CD44v6 as well as anti-CD44v7 significantly mitigated the DNFB-induced, TH1-mediated DTH reactions, while only anti-CD44v7 interfered with a FITC-induced, TH2-mediated allergic contact dermatitis. The in vitro analysis of cytokine producing cells supported the assumption. In conclusion, it could be demonstrated that CD44v6 and CD44v7 are differentially involved in TH1 and TH2 activation and, most importantly, a TH1-mediated autoimmune disease could be prevented by local application of anti-CD44v7.
Asunto(s)
Receptores de Hialuranos/inmunología , Hipersensibilidad Tardía/inmunología , Hipersensibilidad/inmunología , Animales , Anticuerpos/inmunología , Variación Genética , Receptores de Hialuranos/biosíntesis , Receptores de Hialuranos/genética , Ratones , Células TH1/inmunología , Células Th2/inmunologíaRESUMEN
Cloned murine endothelial cells (cEC) were used as a carrier system for introducing a foreign gene into the microvascular bed of the hind limb of inbred mice. cEC were transfected with a beta-galactosidase-neo fusion construct, which enables both selection for DNA uptake in the presence of G 418 and the staining of cells for beta-galactosidase activity. Transfected cEC adhered and integrated readily into confluent monolayers of nontransfected cEC (up to 26% of total cell number). Seeding lacZ-transfected cEC on explanted arteries revealed rapid adhesion of the cells (within minutes) to the intact endothelium. After injection of 10(6) transfected EC via the femoral artery into the microvascular bed of the hind limb their presence was documented by beta-galactosidase staining after various time periods (1 h to 4 wk). Implanted cEC were detected in numerous elements of the microcirculation both in frozen sections and in squash preparations of the hind limb muscle and in the femoral bone up to 4 wk after the injection. The microvascular bed of skeletal muscle of the mouse as a recipient site for transduced syngeneic endothelial cells is, thus, a suitable experimental model to study various strategies for somatic gene therapy.
Asunto(s)
Endotelio Vascular/enzimología , Músculo Esquelético/irrigación sanguínea , beta-Galactosidasa/metabolismo , Animales , Southern Blotting , Células Clonales , Técnicas de Transferencia de Gen , Operón Lac , Ratones , Ratones Endogámicos BALB C , Microcirculación , beta-Galactosidasa/genéticaAsunto(s)
Colitis/inmunología , Citocinas/genética , Receptores de Hialuranos/genética , Receptores de Hialuranos/fisiología , Empalme Alternativo , Animales , Enfermedades Autoinmunes/genética , Moléculas de Adhesión Celular/genética , Moléculas de Adhesión Celular/fisiología , Transformación Celular Neoplásica/genética , Transformación Celular Neoplásica/inmunología , Colitis/inducido químicamente , Colitis/genética , Exones , Genes MHC Clase II , Variación Genética , Hematopoyesis , Ratones , Ratones Endogámicos C57BL , Ratones Endogámicos , Ratones Noqueados , Isoformas de Proteínas/genética , Isoformas de Proteínas/fisiología , Receptores de Interferón/deficiencia , Receptores de Interferón/genética , Receptores de Interferón/fisiología , Recombinación Genética , Células TH1/inmunología , Receptor de Interferón gammaRESUMEN
The earliest T cells homing to the thymus (CD3-CD4loCD8-) express CD117 (c-kit), CD43 (leukosialin), and the integrins CD11a (alphaL), CD11b (alphaM), CD29 (beta1), CD49f (alpha6), and CD44. Using reagents specific for CD44 variant isoforms (CD44v), we demonstrated that CD44v were expressed on virtually all early thymocytes,whereas cells carrying only the standard molecule (CD44s, not containing any variant domains), which is ubiquitously found on mature lymphocytes later, are very sparse. The expression of CD44v was closely correlated with CD43 and CD117 and was restricted to the CD3-CD4loCD8- stage. CD44v were detected on lymphocyte progenitor populations in the fetal blood, liver, thymus and spleen, as well as in the adult bone marrow. Functional studies demonstrated that only cells expressing CD44v from fetal liver and adult bone marrow could efficiently populate fetal thymic stroma and develop into mature T cells. In fetal thymic organ cultures anti-CD44v antibodies specifically blocked thymocyte development. We also present evidence that CD44v were required for the initial interaction of hematopoietic progenitor cells with the thymic stroma. Our data imply that CD44v are not only a useful marker for hematopoietic progenitors, but also play a functional role in the initiation of thymocyte development.
Asunto(s)
Antígenos CD , Hematopoyesis , Receptores de Hialuranos/fisiología , Linfocitos T/fisiología , Animales , Anticuerpos Monoclonales/inmunología , Femenino , Células Madre Hematopoyéticas/química , Leucosialina , Ratones , Ratones Endogámicos C57BL , Isoformas de Proteínas , Proteínas Proto-Oncogénicas c-kit/análisis , Sialoglicoproteínas/análisis , Células del Estroma/fisiología , Timo/citologíaRESUMEN
During mouse early development cell adhesion molecules are indispensable for the embryo organisation. A family of molecules probably involved in development is the transmembrane glycoprotein CD44 family, which exists in multiple isoforms. These are generated by alternative splicing of the pre-mRNA, resulting in the enlargement of the extracellular part of the molecule. The standard form of CD44 is widely expressed in adult tissues and in embryos from day 9.5 post coitum onwards, while the numerous variant isoforms exhibit highly specialised patterns of expression that are already in the egg cylinder at day 6.5 of development. In lymphohemopoiesis, specific variant isoforms also emerge at decisive differentiation stages. Although specific ligands for the variant region still await isolation, the highly organised expression of CD44 variant isoforms suggests they have a pivotal role in cellular interactions during early development, pattern formation and hemopoiesis.
Asunto(s)
Proteínas Portadoras/biosíntesis , Receptores de Superficie Celular/biosíntesis , Receptores Mensajeros de Linfocitos/biosíntesis , Empalme Alternativo , Animales , Proteínas Portadoras/genética , Diferenciación Celular , Desarrollo Embrionario y Fetal , Regulación del Desarrollo de la Expresión Génica , Hematopoyesis , Receptores de Hialuranos , Ratones , ARN Mensajero/biosíntesis , ARN Mensajero/genética , Receptores de Superficie Celular/genética , Receptores Mensajeros de Linfocitos/genéticaRESUMEN
BACKGROUND: Hemodynamic patterns and the distribution of blood volume are influenced by the onset of labour. This study evaluates patterns of oxygenation and changes of blood volume after the induction of contractions. METHODS: A prototype NIR-laser spectrometer was applied in 28 cases. RESULTS: We found a rise of blood volume and oxygen saturation (HbO2) during the peak of contractions. Cerebral tissue oxygenation was monitored by registration of relative changes of cytochrome-aa3. No significant change of tissue oxygenation was detected during variable volume load. DISCUSSION: This implicates compliance of the redox state during labour.
Asunto(s)
Volumen Sanguíneo/fisiología , Encéfalo/irrigación sanguínea , Hipoxia Fetal/fisiopatología , Oxígeno/sangre , Espectroscopía Infrarroja Corta/instrumentación , Contracción Uterina/fisiología , Cardiotocografía , Diseño de Equipo , Femenino , Hipoxia Fetal/diagnóstico , Humanos , Recién Nacido , Embarazo , Sensibilidad y EspecificidadRESUMEN
Inflammatory bowel disease is a quite severe chronic inflammation, treated mainly by immunosuppression, which often has serious side effects. As CD44 is important in lymphocyte activation and migration, we asked whether Abs against CD44 isoforms influence trinitrobenzenesulfonic acid (TNBS)-induced colitis in mice. A lethal colitis (73/111 mice) could be prevented in 69 of 97 mice by anti-CD44v7 (CD44 variant isoform v7), whereas anti-CD44s (CD44 standard isoform) and anti-CD44v6 had no effect. Upon receiving anti-CD44v7 after the disease had been fully exacerbated, >90% of the mice recovered. TNBS plus anti-CD44v7-treated mice developed early signs of inflammation, with infiltration of leukocytes in the lamina propria and increased IFN-gamma production. However, while control mice developed a severe pancolitis, the intestine fully regenerated in anti-CD44v7-treated mice. Locally and systemically, a strong increase in IL-10 production was noted. Thus, anti-CD44v7 can be regarded as a highly efficient and specific therapeutic reagent in chronic colitis, which probably functions by regulating an overshooting Th1 reaction.
Asunto(s)
Anticuerpos Monoclonales/uso terapéutico , Especificidad de Anticuerpos , Colitis/inmunología , Colitis/prevención & control , Receptores de Hialuranos/inmunología , Ácido Trinitrobencenosulfónico , Animales , Colitis/inducido químicamente , Colitis/patología , Citocinas/biosíntesis , Receptores de Hialuranos/biosíntesis , Enfermedades Inflamatorias del Intestino/inmunología , Enfermedades Inflamatorias del Intestino/prevención & control , Mucosa Intestinal/patología , Ratones , Ratones Endogámicos BALB C , Células TH1/inmunología , Células TH1/metabolismoRESUMEN
CD44 variant isoforms (CD44v) are generated by alternative splicing of the nuclear RNA resulting in the expression of additional protein domains in the extracellular region of the CD44 standard molecule (CD44s). In multiple myeloma (MM), CD44 mediates binding of tumor cells to stroma and regulates interleukin-6 production. To evaluate the role of CD44v isoforms in MM, CD44v expression was analyzed by immunohistochemical staining of 64 bone marrow biopsies from 38 MM patients. Expression of variant isoforms containing the 9v domain was observed in 36% of cases and was associated with an advanced stage (P < .02; n = 61), a progressive disease (P < .001; n = 61), and a shorter overall survival (P < .02; n = 36). In contrast, 3v, 4v, 6v, or 10v isoforms were detected only in a small percentage of the patients. To analyze the exon composition in RNA-transcripts, reverse transcriptase polymerase chain reaction analyses followed by Southern hybridization with exon-specific probes were performed in fluorescence-activated cell sorted myeloma plasma cells. Tumors expressing the 9v domain showed complex, 9v-containing transcripts in combinations with the 3v, 7v, 8v, and 10v exons. Identical transcripts were detected in several myeloma cell lines and in a Ki-1 B-immunoblastic lymphoma. Similar to high-grade non-Hodgkin's lymphoma and gastric and renal cell carcinoma, overexpression of 9v-containing isoforms in MM is related to an unfavorable clinical presentation and represents a new prognostic parameter.
Asunto(s)
Antígenos de Neoplasias/genética , Regulación Neoplásica de la Expresión Génica , Receptores de Hialuranos/genética , Mieloma Múltiple/genética , Empalme del ARN , ARN Mensajero/genética , ARN Neoplásico/genética , Adulto , Anciano , Antígenos de Neoplasias/biosíntesis , Biomarcadores de Tumor , Médula Ósea/patología , Adhesión Celular , Progresión de la Enfermedad , Exones/genética , Femenino , Humanos , Receptores de Hialuranos/biosíntesis , Masculino , Persona de Mediana Edad , Mieloma Múltiple/mortalidad , Mieloma Múltiple/patología , PronósticoRESUMEN
Interactions between mononuclear cells are required for the formation of inflammatory infiltrates in the CNS and the activation of cellular effector functions provoking demyelination in MS. Membrane-expressed costimulatory molecules are crucial to such interactions. We therefore investigated whether two costimulatory molecules, CD40L (CD154, expressed on activated CD4-possible T cells) and selected CD44-variant isoforms (expressed on activated CD4-positive T cells), are targets for immunotherapy in MS. The model of experimental autoimmune encephalomyelitis (EAE) induced in SJL-mice by immunization with a peptide derived from the proteolipid protein (PLP139-151) was optimized to address these questions. A previous observation that anti-CD40L (CD154) monoclonal antibodies can effectively prevent EAE in this model was confirmed, and extended by demonstrating that CD40 is expressed by cells of the monocytic lineage infiltrating the spinal cord. In vivo treatment with antibody against the standard isoform of CD44 (CD44s or CD44H) did not affect disease burden. In contrast, combined treatment with antibodies against the isoforms CD44v6, v7 and v10, which are thought to be involved in inflammatory processes, reduced the disease burden considerably. In addition, CD44v10-expressing cells were detected in the spinal cord. These data support the idea that CD40-CD40L interactions form a target for immunotherapy of MS, and indicate that cells expressing CD44v6, v7 and/or v10-containing isoforms have such potential as well.